New sensor for monitoring fetal health during late pregnancy
Official title: Measurement and Validation of Fetal Heart and Fetal Movement Signals Detected Via Non-adhesive Sensors
Run by University of Manchester · NCT06952777 · Data updated 2026-11-12
This study is testing a new non-adhesive sensor to see if it can accurately monitor the heart rates of pregnant women and their babies during late pregnancy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 16 Years to 50 Years |
| Sex | Women only |
| Enrollment | 69 (estimated) |
| Sponsor | University of Manchester Academic / other |
| Locations | 1 site (Manchester) |
| Status | Recruiting |
| Started | June 1, 2024 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | May 1, 2025 |
| Trial ID | NCT06952777 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pregnant women over 16 years old with a singleton pregnancy between 28 and 40 weeks gestation and an estimated fetal weight between the 10th and 90th centiles.
✕Probably not a fit
Patients with fetal anomalies, multiple pregnancies, or those unable to provide informed consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to validate a non-adhesive sensor designed to monitor the heart rates of mothers and their babies during late pregnancy. A multidisciplinary team will test the sensor's ability to consistently detect fetal heart signals while minimizing interference from external electrical noise. Up to 24 pregnant women will participate, wearing the sensor in three different late pregnancy time frames to assess its reliability and accuracy compared to current monitoring techniques. The study will also involve basic assessments of the participants' health and the baby's well-being before sensor application.
Why it matters
Potential benefit: If successful, this sensor could provide a reliable method for long-term monitoring of fetal health, potentially identifying distress earlier and improving outcomes.
How similar studies have gone: While similar approaches to fetal monitoring exist, this specific sensor technology is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants will be included if they have a non-anomalous singleton pregnancy after 28 weeks' gestation with an estimated fetal weight \>10th centile \< 90th centile. Participants will be 16 years or over in order that they can give independent consent. Exclusion Criteria: * Participants will be excluded if there are fetal anomalies (as defined by the NHS Fetal Anomaly Screening Programme - https://www.gov.uk/guidance/fetal-anomaly-screening-programme-overview), it is a multiple pregnancy, there is evidence of Fetal Growth Restriction (Estimated Fetal Weight \<10th centile) or if participants cannot speak or do not understand fluent English. Participants will not be able to participate if they are unable to give informed consent. Participants \<16 years of age will be excluded from this study.
Where it's running
-
Manchester University NHS Foundation Trust
Manchester, United Kingdom Recruiting
Study contacts
- Principal investigator: Alexander Heazell, PhD — University of Manchester
- Study coordinator: Alexander Heazell, PhD
- Email: alexander.heazell@manchester.ac.uk
- Phone: +441612766484
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preeclampsia Biomarker Test in African Women
This study tests whether measuring the sFlt-1/PlGF ratio using quick clinic tests helps predict which pregnant women in Africa will develop severe preeclampsia.
-
STV analysis for fetal monitoring in severe early FGR
Researchers are testing whether short-term variation (STV) analysis of fetal monitoring helps improve perinatal survival for pregnant people with severe early fetal growth restriction compared with traditional visual CTG interpretation.
-
Investigation of selective fetal growth restriction in monochorionic twins
This study is trying to find better ways to understand and manage growth problems in one twin of monochorionic twins during pregnancy, while also checking how these issues affect the twins' development later on.
-
Using melatonin to protect the brain in pregnancies with fetal growth restriction
This study is testing if giving melatonin to pregnant women with severe fetal growth restriction can help improve their baby's health and protect against brain injury before birth.
-
Maternal supplementation to improve fetal brain development in growth-restricted pregnancies
This study is testing if giving pregnant women supplements to help their babies' brain development can improve outcomes for babies who are not growing well in the womb.
-
Using ultrasound to improve detection of fetal growth issues
This study is trying to see if using ultrasound in a structured way can help doctors better spot babies that are not growing properly during pregnancy to reduce the risk of stillbirth.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.